S. 5339, also known as the “Medical Innovation Act of 2024,” aims to increase investments in medical research by collecting supplemental payments from pharmaceutical manufacturers. The bill targets companies that have entered into specific settlement agreements and reported...
The bill wants some big drug companies to give extra money if they make a lot of money, so scientists can do more research to find new medicines and help keep people healthy.
H.R. 10238, titled the "Medical Innovation Act of 2024," allows the U.S. government to collect additional payments from drug manufacturers to boost funding for medical research. This bill targets "blockbuster" drugs, which are those generating over $1 billion in net sales and developed using...
The Medical Innovation Act of 2024 is a plan where the U.S. government wants to collect extra money from companies that make really popular and successful medicines. This money will help make sure scientists have enough funds to continue researching and discovering new medical treatments.
Showing 1 to 2 of 2 results